Skip to content

Jeffrey Cummings

  • Director
  • Quality Matters in the Laboratory Ltd
  • 36h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 5203CitationsNumber of citations received by Jeffrey's publications. Updated daily.

Other IDs

Research interests

Quality AssuranceMethod ValidationBiostatisticsClinical ResearchPharmacologyAnalytical ScienceBiomarkersClinical Trials

Co-authors (266)

  • Simon Langdon

Publications (5)

  • A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours

    • Horsley L
    • Cummings J
    • Middleton M
    • et al.
    N/AReaders
    13Citations
    Get full text
  • Interleukin-6 as a therapeutic target in human ovarian cancer

    • Coward J
    • Kulbe H
    • Chakravarty P
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy

    • Hou J
    • Greystoke A
    • Lancashire L
    • et al.
    N/AReaders
    150Citations
    Get full text
  • Specific demonstration of drug-induced tumour cell apoptosis in human xenografts models using a plasma biomarker

    • Olofsson M
    • Cummings J
    • Fayad W
    • et al.
    N/AReaders
    10Citations
    Get full text
  • Inhibition of cancer cell growth by ruthenium(II) arene complexes

    • Morris R
    • Aird R
    • Del Socorro Murdoch P
    • et al.
    N/AReaders
    533Citations
    Get full text

Professional experience

Director

Quality Matters in the Laboratory Ltd

July 2014 - Present